Reta/Cag 12.5MG/2.5MG
Based on tiered pricing: $97.20 per unit
Reta/Cag 12.5MG/2.5MG is a research compound that combines Retatrutide and Cagrilintide, developed for scientific studies in weight management and metabolic regulation.
Key Research Focus Areas:
-
Dual-pathway approach to weight management through Retatrutide + Cagrilintide
-
Investigation of appetite control, satiety, and energy balance
-
Research into glucose regulation, insulin response, and overall metabolism
Description
CAS Number: N/A (research blend)
Molecular Formula: N/A (research blend)
Molecular Weight: N/A (research blend)
Form: Lyophilized Powder
Quantity: 12.5mg/2.5mg vial
Purity: ≥ 98% (HPLC Verified)
Product Overview:
Retatrutide/Cagrilintide (12.5mg/2.5mg) is a dual-compound research peptide combining Retatrutide, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog. Together, these compounds form a unique research model for studying synergistic mechanisms in appetite regulation, energy expenditure, and metabolic signaling.
This formulation offers researchers the ability to investigate interactions between incretin-based peptides and amylin mimetics in controlled laboratory settings.
Applications in Research:
-
Studies into metabolic regulation and weight management models
-
Appetite suppression and satiety pathway investigations
-
Research on energy balance and glucose homeostasis
-
Exploration of synergistic effects between incretin mimetics and amylin analogs
Storage & Handling:
-
Store lyophilized peptide at -20°C, protected from light and moisture.
-
Reconstitute using sterile bacteriostatic water under aseptic lab conditions.
-
Once reconstituted, store refrigerated and use within appropriate timeframes.
-
Avoid repeated freeze-thaw cycles.
⚠️ Research Use Only – Legal Disclaimer
All products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease.
Simple Peptide is a chemical supplier. Simple Peptide is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Simple Peptide is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.
All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption.
